IFN-γ: A cytokine essential for rejection of CTL-resistant, virus-infected cells

Journal of Interferon and Cytokine Research

Volumn 25, Issue 6, 2005, Pages 328-337

  Yamaguchi, Satoko ^a   Tashiro Yamaji, Junko ^a   Lee, Koutetsu ^a   Takahashi, Takeshi ^a   Sano, Kouichi ^a   Endo, Yasuo ^b   Nakanishi, Mahito ^c   Eguchi, Akiko ^c   Okada, Masashi ^a   Nomi, Hayahito ^a   Yamamoto, Yumiko ^a   Takenaka, Hiroshi ^a   Kubota, Takahiro ^a   Yoshida, Ryotaro ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; CYTOKINE; GAMMA INTERFERON; LIPOSOME; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FIBROSARCOMA; MACROPHAGE; MOUSE; NONHUMAN; PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; T CELL LEUKEMIA; VIRUS INFECTION;

ANIMALS; CELL LINE, TUMOR; CELL TRANSPLANTATION; GRAFT REJECTION; INTERFERON TYPE II; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RESPIROVIRUS INFECTIONS; SENDAI VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

SENDAI VIRUS;

EID: 21344439541     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2005.25.328     Document Type: Article

References (45)

1. DE WAAL, L.P., KAST, W.M., MELVOLD, R.W., and MELIEF, C.J. (1983). Regulation of the cytotoxic T lymphocyte response against Sendai virus analyzed with H-2 mutants. J. Immunol. 130, 1090-1096.
2. + T cells. J. Exp. Med. 174, 875-880.
3. + T cells. J. Immunol. 149, 1319-1325.
4. LEE, K., TAKENAKA, H., YONEDA, Y., GOTO, T., SANO, K., NAKANISHI, M., EGUCHI, A., OKADA, M., TASHIRO, J., SAKURAI, K., KUBOTA, T., and YOSHIDA, R. (2004). Differential susceptibility of cells expressing allogeneic MHC or viral antigen to killing by antigen-specific CTL. Microbiol. Immunol. 48, 15-25.
5. KONDO, T., YOSHIDA, T., MIURA, N., and NAKANISHI, M. (1993). Temperature-sensitive phenotype of a mutant Sendai virus strain is caused by its insufficient accumulation of the M protein. J. Biol. Chem. 268, 21924-21930.
6. YANG, Y., XIANG, Z., ERTL, H.C.J., and WILSON, J.M. (1995). Upregulation of class I major histocompatibility complex antigens by interferon-γ is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92, 7257-7261.
7. HORWITZ, M.S., KRAHL, T., FINE, C., LEE, J., and SARVETNlCK, N. (1999). Protection from lethal Coxsackievirus-induced pancreatitis by expression of gamma interferon J. Virol. 73, 1756-1766.
8. HORWITZ, M.S., LA CAVA, A., FINE, C., RODRIGUEZ, E., ILIC, A., and SARVETNICK, N. (2000). Pancreatic expression of interferon-gamma protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis. Nat. Med. 6, 693-697.
9. KYUWA, S., TAGAWA, Y., SHIBATA, S., DOI, K., MACHII K., and IWAKURA, Y. (1998). Murine coronavirus-induced sub-acute fatal peritonitis in C57BL/6 mice deficient in gamma interferon. J. Virol. 72, 9286-9290.
10. BINDER, G.K., and GRIFFIN, D.E. (2001). Interferon-γ-mediated site-specific clearance of alphavirus from CNS neurons. Science 293, 303-306.
11. GEIGER, K.D., NASH, T.C., SAWYER, S., KRAHL, T., PATSTONE, G., REED, J.C., KRAJEWSKI, S., DALTON, D., BUCHMEIER, M.J., and SARVETNICK, N. (1997). Interferon-γ protects against herpes simplex virus type-1-mediated neuronal death. Virology 238, 189-197.
12. KOUSTOVA, E., SEI, Y., McCARTY, T., ESPEY, M.G., MING, R., MORSE, H.C., III, and BASILE, A.S. (2000). Accelerated development of neurochemical and behavioral deficits in LP-BM5 infected mice with targeted deletions of IFN-gamma gene. J. Neuroimmunol. 108, 112-121.
13. PATTERSON, C.E., LAWRENCE, D.M., ECHOLS, L.A., and RALL, G.F. (2002). Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J. Virol. 76, 4497-4506.
14. YOSHIDA, R., PARK, S.W., YASUI, H., and TAKIKAWA, O. (1988). Tryptophan degradation in transplanted tumor cells undergoing rejection. J. Immunol. 141, 2819-28123.
15. TAKIKAWA, O., HABARA-OHKUBO, A., and YOSHIDA, R. (1990). IFN-γ is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection. J. Immunol. 145, 1246-1250.
16. YOSHIDA, R., TAKIKAWA, O., OKU, T., and HABARAOHKUBO, A. (1991). Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice. Proc. Natl. Acad. Sci. USA 88, 1526-1530.
17. TAKIKAWA, O., OKU, T., YASUI, H., and YOSHIDA, R. (1993). Synergism between IFN-γ and IL-1α/β in growth inhibition of an allografted tumor. J. Immunol. 151, 2070-2076.
18. USHIO-UMEDA, Y., and YOSHIDA, R. (1997). Mechanisms of allografted tumor rejection: the roles of T cells in allograft rejection mediated by a type of bone marrow-derived macrophage. Microbiol. Immunol. 41, 981-990.
19. 2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage. J. Immunol. 159, 15-21.
20. YONEDA, Y., and YOSHIDA, R. (1998). The role of T cells in allografted tumor rejection: IFN-γ released from T cells is essential for induction of effector macrophages in the rejection site. J. Immunol. 160, 6012-6017.
21. NAKANISHI, M., UCHIDA, T., SUGAWA, H., ISHIURA, M., and OKADA, Y. (1985). Efficient introduction of contents of liposomes into cells using HVJ (Sendai virus). Exp. Cell Res. 159, 399-409.
22. TADOKORO, J. (1958). Modified virus particles in undiluted passage of HVJ. II. The characteristics of modified particles. Biken J. 1, 118-128.
23. VAN ROOIJEN, N., KORS, N., ENDE, M., and DIJKSTRA, C. D. (1990). Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res. 260, 215-222.
24. USHIO, Y., YAMAMOTO, N., SANCHEZ-BUENO, A., and YOSHIDA, R. (1996). Failure to reject an allografted tumor after elimination of macrophages in mice. Microbiol. Immunol. 40, 489-498.
25. NAKAMURA, M., SHIBAZAKI, M., NITTA, Y., and ENDO, Y. (1998). Translocation of platelets into Disse spaces and their entry into hepatocytes in response to lipopolysaccharides, interleukin-1 and tumor necrosis factor: the role of Kupffer cells. J. Hepatol. 28, 991-999.
26. ASCHER, N., FERGUSON, R.M., HOFFMAN, R., and SIMMONS, R.L. (1979). Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation 27, 254-259.
27. WINN, H.J. (1961). Immune mechanisms in homotransplantation II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. J. Immunol. 86, 228-239.
28. GREEN, M.I, FUJIMOTO, S., and SEHON, A.H. (1977). Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing host. J. Immunol. 119, 757-764.
29. KÄGI, D., VIGNAUX, F., LEDERMANN, B., BURKI, K., DEPRAETERE, V., NAGATA, S., HENGARTNER, H., and GOLSTEIN, P. (1994). Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265, 528-530.
30. KÄGI, D., SEILER, P., PAVLOVIC, J., LEDERMANN, B., BURKI, K., ZINKERNAGEL, R.M., and HENGARTNER, H. (1995). The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic virus. Eur. J. Immunol. 25, 3256-3262.
31. KAFROUNI, M.I, BROWN, G.R., and THIELE, D.L. (2001). Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms. J. Immunol. 167, 1566-1574.
32. ELKON, K.B., LIU, C.C., GALL, J.G., TREVEJO, J., MARINO, M.W., ABRAHAMSEN, K.A., SONG, X., ZHOU, J.L., OLD, L.J., and CRYSTAL, R.G. (1997). Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc. Natl. Acad. Sci. USA 94, 9814-9819.
33. MULLBACHER, A., EBNET, K., BLANDEN, R.V., HLA, R.T., STEHLE, T., MUSETEANU, C., and SIMON, M.M. (1996). Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia. Proc. Natl. Acad, Sci. USA 93, 5783-5787.
34. GORMAN, W.L., GILL, D.S., SCROGGS, R.A., and PORTNER, A. (1990). The hemagglutinin-neuraminidases of human parainfluenza virus type I and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity. Virology 175, 211-221.
35. GUIDOTTI, L.G., ISHIKAWA, T., HOBBS, M.W., MATZKE, B., SCHREIBER, R., and CHISARI, F.V. (1996). Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4, 25-36.
36. GUIDOTTI, L.G., and CHISARI, F.V. (2000). Cytokine-mediated control of viral infections. Virology 273, 221-227.
37. TAKEDA, K., TSUTSUI, H., YOSHIMOTO, T., ADACHI, O., YOSHIDA, N., KISHIMOTO, T., OKAMURA, H., NAKANISHI, K., and AKIRA, S. (1998). Defective NK activity and Th1 response in IL-18-deficient mice. Immunity 8, 383-390.
38. WONG, G.H., CLARK-LEWIS, I., McKIMM-BRESCHKIN, J.L., HARRIS, A.W., and SCHRADER, J.W. (1983). Interferon-gamma induces enhanced expression of Ia and H-2 antigen on B lymphoid, macrophage, and myeloid cell lines. J. Immunol. 131, 788-793.
39. LJUNGGREN, H.G., and K. KARRE. (1990). In search of the "missing self": MHC molecules and NK cell recognition. Immunol. Today 11, 237-244.
40. YOSHIDA, R., MATSUURA, A., EINAGA, K., USHIO, Y., YAMAMOTO, N., and YONEDA, Y. (1997). Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens. Microbiol. Immunol. 41, 149-159.
41. YAMAMOTO, N., EINAGA-NAITO, K., KURIYAMA, M., KAWADA, Y., and YOSHIDA, R. (1998). Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells. Transplantation 65, 818-825.
42. YOSHIDA, R., OKU, T., TAKIKAWA, O., EINAGA-NAITO, K., YONEDA, Y., HIROTA, R., and KUBOTA, T. (2000). Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts. Microbiol. Immunol. 44, 57-67.
43. DELGADO-ENCISO, I., ROJAS-MARTINEZ, A., BARRERA-SALDANA, H.A., and ORTIZ-LOPEZ, R. (2004). Viruses: an important cause of human cancer. Rev. Invest. Clin. 56, 495-506.
44. CHAN, A.T., TEO, P.M., and HUANG, D.P. (2004). Pathogenesis and treatment of nasopharyngeal carcinoma. Semin. Oncol. 31, 794-801.
45. TSAI, J.H., TSAI, C.H., CHENG, M.H., LIN, S.J., XU, F.L., and YANG, C.C. (2004). Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J. Med. Virol. 75, 276-281.